Ashutosh Tewari

    • Ashutosh (Ash) K. Tewari, MD, Chairman, Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai is a world-renowned urologist and prostate cancer specialist. As Director of the Department of Urology, he leads a multidisciplinary team committed to improving prostate cancer treatment, research and education. To date, he has performed over 5,000 robotic radical prostatectomy surgeries. The Tewari Lab is working on unlocking the genomic causes of prostate cancer and translating genomic information to practical physician application through imaging. In 2012, he was awarded the American Urological Association’s Gold Cystoscope Award. This honor is given annually to the urologist who has contributed significantly to the field within 10 years of completing residency. Dr. Tewari holds several leadership positions domestically and internationally.


    • Dr. Tewari received his undergraduate and medical degrees at GSVM Medical College (Kanpur, India). During medical school he was awarded 17 Gold Medals for outstanding performance on university exams. Dr. Tewari completed his first urology residency at Sanjay Gandhi Post Graduate Institute of Medical Sciences (Lucknow, India). He completed fellowships in urologic-oncology at University of California, San Francisco and the University of Florida (Gainesville, FL). In 2004, he completed his second urology residency at Henry Ford Hospital (Detroit, Michigan). While at Henry Ford, Dr. Tewari was part of the team that performed the first robotic radical prostatectomy in the United States.


    • Dr. Tewari’s case series is one of the largest in the world and his outcomes are considered the gold standard for this procedure. Dr. Tewari’s clinical expertise in prostate cancer includes targeted biopsies, cystoscopies, robotic prostatectomies, as well as the management of active surveillance prostate cancer patients. He has also initiated clinical protocols investigating the utility of focal therapy platforms for the treatment of prostate cancer. Dr. Tewari has been consecutively listed in New York Magazine’s Top Doctors issue since 2006.



robotic surgery, laparoscopy, prostate cancer, 



Chair, Urology, Icahn School of Medicine


  • MBBS, G.S.V.M. Medical College

  • Residency, Surgery 
    G.S.V.M. Medical College

  • Residency, Urology 
    Henry Ford Hospital

  • Fellowship, Transplant 
    University of Liverpool

  • Fellowship, Urology Oncology 
    University of California - San Francisco

  • Fellowship, Urology Oncology 
    University of Florida

  • Fellowship, Urology Oncology 
    Henry Ford Hospital

  • 2012 - 
    Gold Cytoscope Award 

  • 2012 - 
    Most Compassionate Doctor Award 

  • 2012 - 
    First Prize Best Abstract 

  • 2011 - 
    American Society of Clinical Oncology Merit Award 

  • 2011 - 
    Yahya Cohen Memorial Lecture and Medal 
    College of Surgeons of Singapore

  • 2009 - 
    BJU International Visiting Professor Award 

  • 2009 - 
    Syme Medal 
    Royal College of surgeons of Edinburgh

  • 2008 - 
    Grand Prize 
    International College of Surgeons Research Essay

  • 2007 - 2013 
    America's Best Doctors 
    Castle Connolly

    • Dr. Tewari is affiliated with over 40 professional associations and organizations, including:


    • -Member, American Urological Association


    • -Member, Society of Minimally Invasive Surgery


    • -Member, Society of Robotic Surgery (SRS)


    • -Member, Society of Urologic Oncology (SUO)


    • -Fellow, New York Academy of Medicine


    • -Associate Editor, AUA News


    • -Associate Editor, BJUI


    • -Reviewer, Journal of Urology


    • -Reviewer, European Urology

Knelson EH, Gaviglio AL, Tewari AK, Armstrong MB, Mythreye K, Blobe GC. Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma. The Journal of clinical investigation 2013 Oct;.

Nguyen DP, Li J, Yadav SS, Tewari AK. Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer. BJU international 2013 Oct;.

Ali A, Nguyen DP, Tewari A. Robot assisted laparoscopic prostatectomy in 2013. Minerva chirurgica 2013 Oct; 68(5).

Kluth LA, Xylinas E, Rieken M, Chun FK, Fajkovic H, Becker A, Karakiewicz PI, Passoni N, Herman M, Lotan Y, Seitz C, Schramek P, Remzi M, Loidl W, Guillonneau B, Rouprêt M, Briganti A, Scherr DS, Graefen M, Tewari AK, Shariat SF. Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?. Urologic oncology 2013 Sep;.


Nguyen DP, Li J, Tewari AK. Inflammation and prostate cancer: the role of interleukin-6. BJU international 2013 Sep;.


Rieken M, Kluth LA, Xylinas E, Seitz C, Fajkovic H, Karakiewicz PI, Lotan Y, Briganti A, Loidl W, Faison T, Crivelli JJ, Scherr DS, Bachmann A, Tewari AK, Kautzky-Willer A, Pummer K, Shariat SF. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy. Prostate cancer and prostatic diseases 2013 Dec; 16(4).

Tewari N, Zaitoun AM, Lindsay D, Abbas A, Ilyas M, Lobo DN. Three cases of concomitant intraductal papillary mucinous neoplasm and pancreatic neuroendocrine tumour. JOP : Journal of the pancreas 2013 Jul; 14(4).

Sangwan A, Tewari S, Narula SC, Sharma RK, Sangwan P. Significance of periodontal health in primary immune thrombocytopenia- a case report and review of literature. Journal of dentistry (Tehran, Iran) 2013 Mar; 10(2).